Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 31, 2022, Robert W. Hooper, a Class II member of the Board of Directors (the "Board") of Imunon, Inc. (the "Registrant"), announced that he has decided to retire from the Registrant's Board effective December 31, 2022. Mr. Hooper has served on the Registrant's Board since July 2010 and was the chairman of the Board's Compensation Committee. Reaching the age of 75 years of age in 2022, Mr. Hooper intends to retire for personal reasons and not because of any disagreement with management or the Board relating to the Registrant's operations, policies or practices. Mr. Hooper's current term as a Class II director was scheduled to end at the Registrant's 2024 Annual Meeting of Stockholders.

© Edgar Online, source Glimpses